PATENT CLAIM ANALYSIS

Application Number: 16059270
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["546", "332000"]

Abstract:
The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.

Claim (Index 8):
The compound according to  claim 1 , which is represented by general formula (II-1): wherein R 6  is a hydrogen atom or halogen, and the other symbols represent the same meaning as described in  claim 1 , a salt thereof, a solvate thereof, or a cocrystal thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.23684
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15671428', '15515243', '16095374', '15034905', '13982052']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.831882052699585
- 35 USC 102 Novelty (BERT): 0.5787438009222529
- Combined Prediction Score: 0.8065682275218518
- Mean Citation Score: 415.088984
- Max Citation Score: 536.2969400000002
- Similarity Product: 389.7594358184887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test